Pfizer Inc. bounced back in a big way from a GLP-1 trip-up this spring by making known its plan to take over what Metsera Inc ...

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing Cookie Settings ...

Experts agree that the earlier Alzheimer's disease is detected, the sooner action can be taken. And so, the key to preventing ...

BioWorld Content on Product CategoriesMore About Advertise with BioWorld Archives Article reprints and permissions Contact us Cookie policy Copyright notice Data ...

The second day’s meeting of the U.S. CDC’s Advisory Committee for Immunization Practices (ACIP) took up guidelines related to COVID-19 vaccines, of which an outspoken skeptic is Health and Human ...

Following the first approvals in the U.K., Canada, Australia and Switzerland, the EMA’s Committee for Medicinal Products for ...

Medtronic plc received U.S. FDA approval for Altaviva, a minimally invasive implantable tibial neuromodulation device ...

At the ongoing European Association for the Study of Diabetes annual meeting in Vienna, Hanmi Holdings Co. Ltd. presented preclinical efficacy data on HM-15275, a long-acting GLP-1/GIP/glucagon ...

Two back-to-back papers published in Nature on Sept. 10, 2025, shed new light on the unexpected role of neurons in shaping the evolution of small-cell lung cancer (SCLC). It’s already known that, in ...

Osteosarcoma, the most common bone cancer in children and young adults, has poor outcomes after relapse with only ~18% 5-year survival, underscoring the urgent need for new therapies. Researchers from ...

A committee of the House of Representatives advanced a bill that if passed will give eligible breakthrough medical devices ...